Theresa Lowry
Ufficiale delle Risorse Umane presso ZURA BIO LIMITED
Provenienza dei contatti di primo grado di Theresa Lowry
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Biotechnology | 17 | |
| Public Company | Biotechnology | 12 | |
| Public Company | Pharmaceuticals: Major | 9 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Theresa Lowry tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Comptroller/Controller/Auditor Corporate Officer/Principal Director/Board Member | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
| REGENERON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| CITIGROUP INC. | Major Banks | Corporate Officer/Principal | |
| AGILENT TECHNOLOGIES, INC. | Medical Specialties | Public Communications Contact | |
| ILLUMINA, INC. | Biotechnology | Public Communications Contact | |
| ARENA PHARMACEUTICALS | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer Director/Board Member Director/Board Member Corporate Officer/Principal Compliance Officer | |
QuatRx Pharmaceuticals Co.
 QuatRx Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology QuatRx Pharmaceuticals Co. manufactures and develops therapeutic compounds. Its clinical products, ospemifene and fispemifene, treat hormone deficiencies that result from aging in women and men. The firm's preclinical program is designed to address sex steroid dependent diseases through inhibition of 17beta- hydroxysteroid dehydrogenase (HSD) enzymes. The company was founded by Robert Zerbe, Christopher Nicholas, and Stuart Dombey on November 20 2000 and is headquartered in Ann Arbor, MI. | Pharmaceuticals: Major | Corporate Officer/Principal | |
QVT Financial LP
 QVT Financial LP Investment ManagersFinance QVT Financial LP is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded in 2003 by Daniel Gold. QVT Financial provides administrative and/or investment management services to private funds including US limited partnerships, non-US limited partnerships and non-US Corporation. | Investment Managers | Analyst-Equity | |
| OREXIGEN THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| PRECISION BIOSCIENCES, INC. | Biotechnology | Director/Board Member Public Communications Contact | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member | |
Millendo Therapeutics US, Inc.
 Millendo Therapeutics US, Inc. Pharmaceuticals: MajorHealth Technology Millendo Therapeutics US, Inc. engages in the development of novel treatment for adrenal cancer. It focuses on developing a portfolio of disease-modifying treatments for endocrine disorders caused by hormone dysregulation. The company was founded by Raili E. Kerppola, Julia C. Owens, and Gary D. Hammer in January 2012 and is headquartered in Ann Arbor, MI. | Pharmaceuticals: Major | Director/Board Member Founder | |
| TURG POIN | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| The Trustees of Columbia University in The City of New York | College/University | Graduate Degree Doctorate Degree | |
| Dartmouth College | College/University | Undergraduate Degree | |
The Boston Consulting Group, Inc.
 The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Wilson Sonsini Goodrich & Rosati PC
 Wilson Sonsini Goodrich & Rosati PC Miscellaneous Commercial ServicesCommercial Services Wilson Sonsini Goodrich & Rosati PC provides legal services. Its services include corporate law and governance, public and private offerings of equity and debt securities, mergers and acquisitions, securities class action litigation, intellectual property litigation, antitrust counseling and litigation, joint ventures and strategic alliances, technology licensing and other intellectual property transactions, tax, and employee benefits and employment law. The company was founded in 1961 and is headquartered in Palo Alto, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Claremont McKenna College | College/University | Undergraduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| The University of California, San Francisco | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
| University of St. Andrews | College/University | Graduate Degree | |
| MEDIVATION INC | Pharmaceuticals: Major | Director of Finance/CFO | |
| REGULUS THERAPEUTICS INC. | Pharmaceuticals: Major | Corporate Officer/Principal President | |
GV Management Co. LLC
 GV Management Co. LLC Investment ManagersFinance GV Management Co LLC (Google Ventures) is a venture capital firm, a subsidiary of Google LLC founded in 2009 by Bill Maris. The firm is headquartered in Mountain View, California with an additional office in San Francisco, Boston, New York and London. | Investment Managers | Consultant / Advisor | |
Aragon Pharmaceuticals, Inc.
 Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aragon Pharmaceuticals, Inc. develops biopharmaceutical products, It offers a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers. The company was founded by Charles L. Sawyers and Michael Jung on May 1, 2009 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Director/Board Member Chief Operating Officer | |
Consonance Capital Management LP
 Consonance Capital Management LP Investment ManagersFinance Consonance Capital Management LP (Consonance Capital) is a hedge fund firm headquartered in New York City. The firm was founded in 2007 by Mitchell Blutt, Kevin Livingston, and Benny Soffer. They are a subsidiary of Consonance Capman GP LLC. Consonance Capital provides investment advisory services to private pooled investment vehicles. | Investment Managers | Analyst-Equity | |
| THERAVANCE BIOPHARMA, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Johns Hopkins Bloomberg School of Public Health | College/University | Graduate Degree Corporate Officer/Principal | |
| AUDENTES THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Seragon Pharmaceuticals, Inc.
 Seragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Seragon Pharmaceuticals, Inc. developes biopharmaceutical products for the treatment of estrogen receptor dependent breast cancer. The company was founded in 2013 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Director/Board Member Chief Operating Officer | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree | |
KVP Capital Advisors LP
 KVP Capital Advisors LP Investment ManagersFinance KVP Capital Advisors LP provides investment advice. The private company is based in San Francisco, CA. | Investment Managers | Corporate Officer/Principal | |
| ARCUS BIOSCIENCES, INC. | Biotechnology | Chief Operating Officer | |
| DERMTECH, INC. | Medical Specialties | Investor Relations Contact Chief Tech/Sci/R&D Officer | |
Tourmaline Bio, Inc.
 Tourmaline Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Tourmaline Bio, Inc., Tourmaline Sub, Inc. is a late-stage clinical biotechnology company based in New York, NY. The company's lead program, Tour006, is an anti-IL-6 antibody with high binding affinity and a naturally long half-life. Tour006 has been studied in over 400 autoimmune patients across six clinical trials. Tourmaline Sub plans to develop Tour006 for thyroid eye disease (TED) and atherosclerotic cardiovascular disease (ASCVD), with additional indications being considered. The company, founded in 2021 by Sandeep Kulkarni and Caley M. Castelein, is focused on developing transformative medicines for patients with life-altering immune diseases. Sandeep Kulkarni has been the CEO since 2021. Tourmaline Sub was acquired by Talaris Therapeutics, Inc. on October 19, 2023, for $43.50 million. | Miscellaneous Commercial Services | Founder Director/Board Member | |
| IMMUNOVANT, INC. | Biotechnology | Chief Operating Officer |
Statistiche
Distribuzione geografica
| Stati Uniti | 44 |
| Svizzera | 2 |
| Hong Kong | 2 |
| Regno Unito | 2 |
| Isole Cayman | 2 |
Settori
| Health Technology | 27 |
| Finance | 9 |
| Consumer Services | 9 |
| Commercial Services | 6 |
Posizioni
| Director/Board Member | 140 |
| Corporate Officer/Principal | 88 |
| Independent Dir/Board Member | 47 |
| Chief Executive Officer | 36 |
| Undergraduate Degree | 27 |
Contatti più connessi
| Insiders | |
|---|---|
| Kristina Burow | 40 |
| Carol Gallagher | 39 |
| Amit Munshi | 27 |
| Robert J. Adelman | 25 |
| Jennifer Jarrett | 18 |
| Catherine C. Lee | 17 |
| Jeffrey Jonker | 16 |
| Preston Klassen | 15 |
| Neil Graham | 14 |
| Sandeep Kulkarni | 11 |
| Spyridon Papapetropoulos | 11 |
| Steven Schoch | 11 |
| Hubert Chen | 11 |
| Stephanie Fagan | 11 |
| Ebun Garner | 11 |
- Borsa valori
- Insiders
- Theresa Lowry
- Connessioni Società